Hao Hai Biological Technology (06826.HK) announced its first quarter results, with a net profit attributable to the parent of approximately 90.31 million yuan, a year-on-year decrease of 7.41%.

Wisdom Financial APP news, Haohai Bio-Technology (06826.HK) announced its first quarter performance for 2025, with revenue of approximately 618.5 million yuan, a year-on-year decrease of 4.25%; net profit attributable to shareholders of the listed company was approximately 90.3121 million yuan, a year-on-year decrease of 7.41%; basic earnings per share were 0.39 yuan.